All AbMole products are for research use only, cannot be used for human consumption.
Odevixibat (A4250) is a potent selective ileal bile acid transporter (IBAT) inhibitor. Odevixibat (A4250) mitigates cholestatic liver and bile duct damage in mouse models. Odevixibat (A4250) can be used in the study of primary biliary cirrhosis.
Molecular Weight | 740.93 |
Formula | C37H48N4O8S2 |
CAS Number | 501692-44-0 |
Form | Solid |
Solubility (25°C) | DMSO ≥ 100 mg/mL |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[2] Emma D Deeks. Drugs. Correction to: Odevixibat: First Approval
[3] Emma D Deeks. Drugs. Odevixibat: First Approval
[4] No authors listed. Am J Health Syst Pharm. Odevixibat Sesquihydrate
Related Sodium Channel Products |
---|
LTGO-33
LTGO-33 is a potent and selective voltage-gated sodium channel NaV1.8 inhibitor. |
A-317567
A-317567 is a potent acid-sensing ion channel 3 (ASIC-3) inhibitor with an IC50 of 1.025 μM. |
XPC-6444
XPC-6444 is a highly potent, isoform-selective, and CNS-penetrant NaV1.6 inhibitor (IC50=41 nM for hNaV1.6). |
TC-N 1752
TC-N 1752 is a potent and orally active inhibitor of Nav1.7, with IC50s of 0.17 μM, 0.3 μM, 0.4 μM, 1.1 μM and 2.2 μM at hNav1.7, hNav1.3, hNav1.4, hNaV1.5 and rNav1.8, respectively. |
Nav1.8-IN-4
Nav1.8-IN-4 is a Nav1.8 channel inhibitor (IC50=0.014 μM). |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.